Literature DB >> 8104648

Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.

L Levesque1, G Drapeau, J H Grose, F Rioux, F Marceau.   

Abstract

1. Kinins exert a contractile effect on rabbit aortic rings via the stimulation of B1 receptors. Des-Arg9-bradykinin (BK) is more potent than BK on this receptor type. The mode of action of des-Arg9-BK on rabbit aortic tissue has been studied by both the aortic ring contractility assay and a cellular model using cultured aortic smooth muscle cells (SMCs). 2. The des-Arg9-BK-induced contractions in rabbit aortic rings were unaffected by pretreatments with nifedipine, indomethacin, REV-5901 (a 5-lipoxygenase blocker) and LY-83583 (a guanylyl cyclase inhibitor); however, the protein kinase inhibitors H-7 and H-9 significantly reduced the maximal effect of des-Arg9-BK. 3. The contractile responses to des-Arg9-BK in calcium-free Krebs solution were slightly but not significantly attenuated in amplitude, as compared to paired control tissues bathed in Krebs solution, and sustained plateaus of contraction were observed in the absence of Ca2+. However, Ca2+ replenishment further increased the kinin-induced contraction measured in Ca(2+)-free bathing fluid. 4. Despite the lack of evidence of a mediating role for prostaglandin in the mechanical response to des-Arg9-BK, the kinin stimulated the release of prostacyclin from rabbit aorta rings measured as immunoreactive 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha). 5. Smooth muscle cells (SMCs) derived from the rabbit aorta exhibit functional responses to des-Arg9-BK in acute release of 6-keto-PGF1alpha and of inositol phosphate turnover which were inhibited by pretreatment with the B1 receptor antagonist, Lys[Leu8]des-Arg9-BK, but not by the B2 receptor antagonist, Hoe-140. Preincubation of the cells with interleukin- 1 (IL-1) 20 h before stimulation with the kinin had no effect on basal inositol phosphate turnover, but potentiated the acute effect of des-Arg9-BK.6. These results suggest that second mesengers derived from the action of phospholipase C are produced by SMCs when B1 receptors are activated in rabbit aortic tissue. Intracellular calcium stores are primarily mobilized by des-Arg9-BK, although receptor-controlled calcium influx has not been ruled out, and may contribute to initiate the contractile responses. The maintenance of the contractile state involves protein kinase C activity and is consistent with a current model of SMC function. The cell model retains some of the cardinal properties of B1 receptor-mediated vascular responses: endothelium independent PGI2 release and up-regulation by the cytokine IL-1. PGI2 is not involved in the mechanical response, possible because the rabbit aorta is refractory to this prostaglandin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104648      PMCID: PMC2175773          DOI: 10.1111/j.1476-5381.1993.tb13757.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase.

Authors:  H S Kantor; M Hampton
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.

Authors:  G Drapeau; D deBlois; F Marceau
Journal:  J Pharmacol Exp Ther       Date:  1991-12       Impact factor: 4.030

3.  De novo formation of vascular receptors for bradykinin.

Authors:  D Regoli; F Marceau; J Barabé
Journal:  Can J Physiol Pharmacol       Date:  1978-08       Impact factor: 2.273

4.  Inhibition of iloprost of the contractile effect of noradrenaline in mesenteric artery rings: evidence for a possible calcium-dependent mechanism.

Authors:  E Demirel; R K Türker
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1991-03       Impact factor: 4.006

5.  Expression cloning of a rat B2 bradykinin receptor.

Authors:  A E McEachern; E R Shelton; S Bhakta; R Obernolte; C Bach; P Zuppan; J Fujisaki; R W Aldrich; K Jarnagin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.

Authors:  A Mülsch; A Lückhoff; U Pohl; R Busse; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

7.  Des-Arg9 bradykinin modulates DNA synthesis, phospholipase C, and protein kinase C in cultured mesangial cells. Distinction from effects of bradykinin.

Authors:  M Issandou; J M Darbon
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

8.  On the relation between contraction and prostaglandin release in rabbit mesenteric blood vessels.

Authors:  T Simmet; G Hertting
Journal:  Eur J Pharmacol       Date:  1980-08-08       Impact factor: 4.432

9.  Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery.

Authors:  F Marceau; E Petitclerc; D DeBlois; P Pradelles; P E Poubelle
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

10.  Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1.

Authors:  D deBlois; J Bouthillier; F Marceau
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

View more
  11 in total

1.  Selective enhancement by an adenosine A1 receptor agonist of agents inducing contraction of the rat vas deferens.

Authors:  V R Brownhill; S M Hourani; I Kitchen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

2.  Non-competitive pharmacological antagonism at the rabbit B(1) receptor.

Authors:  J F Larrivée; L Gera; S Houle; J Bouthillier; D R Bachvarov; J M Stewart; F Marceau
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  Absence of ligand-induced regulation of kinin receptor expression in the rabbit.

Authors:  T Sabourin; K Guay; S Houle; J Bouthillier; D R Bachvarov; A Adam; F Marceau
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Wortmannin alters the intracellular trafficking of the bradykinin B2 receptor: role of phosphoinositide 3-kinase and Rab5.

Authors:  Steeve Houle; François Marceau
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

5.  B1 bradykinin receptors and sensory neurones.

Authors:  C L Davis; S Naeem; S B Phagoo; E A Campbell; L Urban; G M Burgess
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  Mode of action of thrombin in the rabbit aorta.

Authors:  D Godin; F Rioux; F Marceau; G Drapeau
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

7.  Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production.

Authors:  J P Galizzi; M C Bodinier; B Chapelain; S M Ly; L Coussy; S Giraud; G Neliat; T Jean
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

8.  Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta.

Authors:  L Levesque; J F Larrivée; D R Bachvarov; F Rioux; G Drapeau; F Marceau
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.

Authors:  S K Butt; L G Dawson; J M Hall
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Bradykinin-induced vasodilation is changed to a vasoconstrictor response in vessels of aged normotensive and hypertensive rats.

Authors:  L Mantelli; S Amerini; F Ledda
Journal:  Inflamm Res       Date:  1995-02       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.